Positive Allosteric Modulators Sector: Growth Drivers and Challenge
Growth Drivers
- Increasing Prevalence of Severe Mental Disorders
- Growing Medical Research and Development Activities
Challenges
-
Side Effects of the Drugs
-
Poor Adoption of Advanced Technology in Low-income Regions
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Positive Allosteric Modulators Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037.
The increasing prevalence of Parkinson’s disease, schizophrenia, Alzheimer’s disease, and other mental disorder will boost the market growth.
Asia Pacific industry is likely to hold largest revenue share by 2037, on account of increasing investment in development of healthcare sector in the region, along with growing health awareness amongst the population.
The major players in the market are Eli Lilly and Company, Novartis AG, Bayer AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, and Pfizer Inc.
